000 | 01259na a2200205 4500 | ||
---|---|---|---|
999 |
_c1515 _d1515 |
||
003 | PC1515 | ||
005 | 20181214121829.0 | ||
008 | 130622s2013 xxx||||| |||| 00| 0 eng d | ||
040 | _cH12O | ||
041 | _aeng | ||
100 |
_aBenito León, Julián _9892 _eNeurología |
||
100 |
_aSánchez Ferro, Álvaro _91767 _eNeurología |
||
245 | 0 | 4 |
_aThe management of orthostatic hypotension in Parkinson's disease. _h[artículo] |
260 |
_bFrontiers in neurology, _c2013 |
||
300 | _a4:64. | ||
500 | _aFormato Vancouver: Sánchez-Ferro A, Benito-León J, Gómez-Esteban JC. The management of orthostatic hypotension in Parkinson's disease. Front Neurol. 2013 Jun 10;4:64. | ||
501 | _aPMID: 23772219 | ||
504 | _aContiene 149 referencias | ||
520 | _aOrthostatic hypotension (OH) is a common and disabling symptom affecting Parkinson's disease (PD) patients. We present the effect of the different therapies commonly used to manage PD on this clinical manifestation. For this purpose, we describe the relationship between OH and the current treatments employed in PD, such as L-DOPA, dopaminergic agonists, and continuous dopaminergic stimulation therapies. Additionally, we review the therapeutic measures that could be used to ameliorate OH. There are different approaches to deal with this manifestation, including pharmacological and non-pharmacological treatments, although none of them is specifically aimed for treating OH in PD. | ||
710 |
_9267 _aServicio de Neurología-Neurofisiología |
||
856 |
_uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677136/ _yAcceso libre |
||
942 |
_n0 _2ddc _cART |